New Drugs for Preventing MigrainesAschenbrenner, Diane S., MS, RNAJN The American Journal of Nursing: May 2019 - Volume 119 - Issue 5 - p 22 doi: 10.1097/01.NAJ.0000557909.12528.af Drug Watch Buy Abstract Author InformationAuthors Article MetricsMetrics The Food and Drug Administration has approved three drugs from a new drug class designed to prevent migraine headaches. The drugs target calcitonin gene–related peptide, a substance involved in the excessive cerebral vasodilation that leads to migraine headaches. The three new products are administered subcutaneously once per month. Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: firstname.lastname@example.org. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.